Several studies have found that aberrant expression of SOX9 is involved in PCa development and progression, drives the transformation of club cells into stem cells, and that inhibition of SOX9 expression improves the functional characteristics of drug resistance and aggressiveness in PCa (Bian et al. 2024; Nouri et al. 2020). The gene discussed is SOX9; the disease is posterior cortical atrophy.